Effect of Histone Deacetylase HDAC3 on Cytokines IL-18, IL-12 and TNF-α in Patients with Intrahepatic Cholestasis of Pregnancy

被引:21
作者
Shao, Yong [1 ]
Chen, Jing [2 ]
Zheng, Jiao [1 ]
Liu, Cai-Ru [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, 1 Youyi St, Chongqing 400016, Peoples R China
[2] First Peoples Hosp Jiu Long Po Dist, Dept Obstet & Gynecol, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
Intrahepatic cholestasis of pregnancy; Histone deacetylase 3; IL-18; IL-12; TNF-alpha; NF-KAPPA-B; ACTIVATION; APOPTOSIS; CELLS;
D O I
10.1159/000478958
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background/aims: The pathogenesis of intrahepatic cholestasis of pregnancy (ICP) is poorly understood. Objective: This study aimed to explore the possible effect of HDAC3 (histone deacetylase) on cytokines IL-18, IL-12 and TNF-alpha in ICP. Methods: Serum levels of cytokines IL-18, IL-12 and TNF-alpha, bile acids and hepatic function parameters were measured. The expression of HDAC3 in the placenta was determined by immunohistochemistry (IHC), western blotting and RT-PCR. Results: IL-18, IL-12 and TNF-alpha serum levels were significantly higher in the severe ICP group than in the mild ICP group and the control group, and the difference between the mild ICP group and control group was not significant. HDAC3 protein expression was identified in the nucleus of the placental trophoblast by IHC. HDAC3 mRNA and protein expression were significantly lower in the ICP groups (mild ICP and severe ICP groups) than in the control groups, and no significant difference was found between the mild ICP and severe ICP groups. Conclusions: The low expression of HDAC3 and overexpession of inflammatory cytokines (IL-18, IL-12 and TNF-alpha) in ICP may be involved in liver cell apoptosis. We suspect that HDAC3 may play an important role in the pathophysiology of ICP. (C) 2017 The Author(s) Published by S. Karger AG, Basel.
引用
收藏
页码:1294 / 1302
页数:9
相关论文
共 26 条
  • [11] Intrahepatic cholestasis of pregnancy:: Relationships between bile acid levels and fetal complication rates
    Glantz, A
    Marschall, HW
    Mattsson, LÅ
    [J]. HEPATOLOGY, 2004, 40 (02) : 467 - 474
  • [12] Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
    Gregoretti, IV
    Lee, YM
    Goodson, HV
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2004, 338 (01) : 17 - 31
  • [13] Regulated suppression of NF-κB throughout pregnancy maintains a favourable cytokine environment necessary for pregnancy success
    Hadfield, Katrina A.
    McCracken, Sharon A.
    Ashton, Anthony W.
    Nguyen, Tue G.
    Morris, Jonathan M.
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2011, 89 (01) : 1 - 9
  • [14] Immunologic Abnormality of Intrahepatic Cholestasis of Pregnancy
    Hu Yayi
    Wang Danqing
    Liu Shuyun
    Liu Jicheng
    [J]. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2010, 63 (04) : 267 - 273
  • [15] Jin Ping, 2011, Zhonghua Fu Chan Ke Za Zhi, V46, P329
  • [16] Kenyon AP, 2011, 43 RCOG
  • [17] Maternal Lipid Change in Relation to Length of Gestation: A Prospective Cohort Study with Preconception Enrollment of Women
    Laughon, S. Katherine
    McLain, Alexander C.
    Sundaram, Rajeshwari
    Catov, Janet M.
    Louis, Germaine M. Buck
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2014, 77 (01) : 6 - 13
  • [18] Elevated Immunoreactivity against Class I Histone Deacetylases in Adenomyosis
    Liu, Xishi
    Nie, Jichan
    Guo, Sun-Wei
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2012, 74 (01) : 50 - 55
  • [19] Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression
    Mahlknecht, U
    Will, J
    Varin, A
    Hoelzer, D
    Herbein, G
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (06) : 3979 - 3990
  • [20] Regulation of interferon-γ production by IL-12 and IL-18
    Okamura, H
    Kashiwamura, S
    Tsutsui, H
    Yoshimoto, T
    Nakanishi, K
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (03) : 259 - 264